- Abstract
- Core Tip
- Article Highlights
- Full Article with Cover (PDF)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (963)
- Timeline of Article Publication (4)
- Authors Evaluation (3)
- Article Quality Tracking (2)
- Reader Comments (1)
- Reference Citation Analysis (3)
Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8620)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 28, 2021 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Patel A, Spychalski P, Antoszewska M, Regula J, Kobiela J. Proton pump inhibitors and colorectal cancer: A systematic review. World J Gastroenterol 2021; 27(44): 7716-7733 [PMID: 34908809 DOI: 10.3748/wjg.v27.i44.7716] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i44/7716.htm |
| Number | Citing Articles |
| 1 |
Chin-Chia Wu, Chuan-Yin Fang, Ben-Hui Yu, Chun-Ming Chang, Ta-Wen Hsu, Chung-Lin Hung, Shih-Kai Hung, Wen-Yen Chiou, Jui-Hsiu Tsai. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer. Cancers 2023; 15(21): 5304 doi: 10.3390/cancers15215304
|
| 2 |
Soo Hee Jeong, Lara Molloy, Edmond Ang, Nuala Helsby. Re-thinking the possible interaction between proton pump inhibitors and capecitabine. Cancer Chemotherapy and Pharmacology 2022; 90(5): 381 doi: 10.1007/s00280-022-04473-9
|
| 3 |
Elżbieta Wojaczyńska, Jacek Wojaczyński. Sulfoxides in medicine. Current Opinion in Chemical Biology 2023; 76: 102340 doi: 10.1016/j.cbpa.2023.102340
|
| 4 |
Wan-Ying Lin, Shih-Syuan Wang, Yi-No Kang, Andrea S. Porpiglia, Yu Chang, Chin-Hsuan Huang, Ronak Bhimani, Eahab Abdul-Lattif, Muneeba Azmat, Tsu-Hsien Wang, Yu-Shiuan Lin, Yu-Cheng Chang, Kuan-Yu Chi. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1048980
|
| 5 |
Khaled A. N. Abusharkh, Ferah Comert Onder, Venhar Çınar, Zuhal Hamurcu, Bulent Ozpolat, Mehmet Ay. A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells. Medical Oncology 2024; 41(8) doi: 10.1007/s12032-024-02427-0
|
| 6 |
Jean-Louis Legoux, Roger Faroux, Nicolas Barrière, Karine Le Malicot, David Tougeron, Véronique Lorgis, Véronique Guerin-Meyer, Vincent Bourgeois, David Malka, Thomas Aparicio, Matthieu Baconnier, Valérie Lebrun-Ly, Joëlle Egreteau, Faïza Khemissa Akouz, Magali Terme, Côme Lepage, Valérie Boige. First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA). Cancers 2024; 16(8): 1515 doi: 10.3390/cancers16081515
|